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Introduction
Caveolin-1 (Cav1) was originally identified as a component 
of caveolae and a major tyrosine-phosphorylated substrate 
of Src kinase (Glenney and Soppet, 1992; Kurzchalia et al., 1992; 
Rothberg et al., 1992). Caveola formation is critically dependent 
on expression of Cav1 as well as cavin-1/PTRF (polymerase I 
and transcript release factor), which along with cavin-2, -3, 
and -4 forms a protein family whose interaction with Cav1 
impacts Cav1 stability and caveola biogenesis, morphology, 
and dynamics (Hill et al., 2008; Liu and Pilch, 2008; Bastiani 
et al., 2009; Hansen et al., 2009; McMahon et al., 2009). Tyro-
sine phosphorylation of Cav1 on Y14 is associated with Rous 
sarcoma virus transformation (Glenney, 1989; Li et al., 1996) 
and also occurs in response to growth factor stimulation and 
integrin-mediated mechanotransduction (Mastick et al., 1995; 
Kim et al., 2000; Lee et al., 2000; Fielding et al., 2004; Radel 
and Rizzo, 2005). pCav1 promotes integrin and focal adhe-
sion dynamics, activates RhoA GTPase, and stimulates cell 
migration (del Pozo et al., 2005; Grande-García et al., 2007; 
Goetz et al., 2008; Joshi et al., 2008). pCav1 also mediates 
raft-dependent internalization of signaling complexes upon cell 
detachment as well as lipid order and organization within focal 
adhesions (del Pozo et al., 2005; Gaus et al., 2006). Tyrosine 
phosphorylation of Cav1 is required for EGF induction of caveola 
formation and E-cadherin endocytosis at epithelial junctions 
(Orlichenko et al., 2006, 2009). However, whether and how 
tyrosine phosphorylation of Cav1 impacts on caveola formation 
and function remain unknown.
Egr1 is a zinc finger protein and transcription factor 
induced by multiple cellular stimuli, including oxidative or 
mechanical stress (Nose and Ohba, 1996; Stula et al., 2000; Wu 
et al., 2010). The GC-rich consensus sequences that function as 
promoter-binding elements for Egr1 overlap with binding sites 
for the SP1 transcription factor. Competition of Egr1 with SP1 
for these promoter binding sites can silence or decrease target 
gene expression (Silverman et al., 1997; Raychowdhury et al., 
2002; Kubosaki et al., 2009). Egr1 is the substrate of multiple 
Caveolin-1 (Cav1) is an essential component of caveolae whose Src kinase-dependent phos-phorylation on tyrosine 14 (Y14) is associated 
with regulation of focal adhesion dynamics. However, the 
relationship between these disparate functions remains to 
be elucidated. Caveola biogenesis requires expression of 
both Cav1 and cavin-1, but Cav1Y14 phosphorylation 
is dispensable. In this paper, we show that Cav1 ty-
rosine phosphorylation induces caveola biogenesis via 
actin-dependent mechanotransduction and inactivation 
of the Egr1 (early growth response-1) transcription factor, 
relieving inhibition of endogenous Cav1 and cavin-1 genes. 
Cav1 phosphorylation reduces Egr1 binding to Cav1 and 
cavin-1 promoters and stimulates their activity. In MDA-
231 breast carcinoma cells that express elevated levels of 
Cav1 and caveolae, Egr1 regulated Cav1, and cavin-1 
promoter activity was dependent on actin, Cav1, Src, 
and Rho-associated kinase as well as downstream protein 
kinase C (PKC) signaling. pCav1 is therefore a mechano-
transducer that acts via PKC to relieve Egr1 transcriptional 
inhibition of Cav1 and cavin-1, defining a novel feedback 
regulatory loop to regulate caveola biogenesis.
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Figure 1. Cav1 Y14 phosphomimetic induces expression of endogenous Cav1 and cavin-1 and caveolae. (A) Cell lysates of stably transfected MDA-435 
cell lines expressing dsRed, RFP-tagged wild-type Cav1 (Cav1wt), or mutant RFP-tagged Cav1Y14F, Y14D, or 14R were Western blotted for Cav1, show-
ing expression of higher molecular weight RFP-tagged Cav1 and endogenous Cav1, as well as with antibodies to cavin-1 and -actin. A shorter exposure 
of the Cav1 blot shows dramatic increase in endogenous Cav1 and cavin-1 in Cav1Y14D and Y14R MDA-435 cell lines. Densitometric quantification 
427Caveola biogenesis via pCav1 mechanotransduction • Joshi et al.
of exogenous Cav1-mRFP, endogenous Cav1, and cavin-1 relative to -actin are shown (*, P < 0.05). (B) Representative electron micrographs of stable 
Cav1wt-, Y14D-, and Y14R-expressing MDA-435 cells. Cav1Y14D and Y14R cells express increased numbers of single caveolae (arrows indicate typical 
caveolae connected to the cell surface) and surface-connected (ruthenium red positive) caveola clusters (asterisks show connections out of the plane of the 
section). Arrowheads indicate clathrin-coated pits. Insets show additional images of caveolae in Cav1Y14D- and Cav1Y14R-transfected cells. PM, plasma 
membrane. Bars, 200 nm. (C) The number of caveolae per cell profile was quantified for stable MDA-435 transfectants (*, P < 0.01; **, P < 0.001). Error 
bars show means ± SEM.
 
kinases, including PKC, and when phosphorylated fails to bind 
target promoter DNA (Huang and Adamson, 1995; Jain et al., 
1996; Huang et al., 1998). We show here that pCav1 is a mecha-
notransducer that induces transcriptional activation via phos-
phorylation of the master regulator Egr1 and of the Cav1 and 
cavin-1 genes, thereby inducing caveola formation. This there-
fore represents the first mechanistic link between Cav1 induction 
of caveolae and focal adhesion regulation by pCav1. Together 
with the role of caveolae as a plasma membrane reservoir to 
buffer membrane surges upon mechanical cell stress (Sinha 
et al., 2011), this study defines Cav1 as a critical mechanotrans-
ducer that regulates the cellular response to mechanical stress.
Results and discussion
Cav1 Y14 phosphorylation induces  
caveola biogenesis through expression  
of Cav1 and cavin-1
The MDA-435 cancer cell line expresses low levels of Cav1 and 
few caveolae (Kojic et al., 2007). Stable transfection of MDA-435 
cells with wild-type, dominant-negative Y14F, phosphomimetic 
Y14D, or positively charged Y14R C-terminal monomeric RFP 
(mRFP)–tagged Cav1 (Goetz et al., 2008; Joshi et al., 2008) 
results in stable expression of the exogenous, higher molecular 
weight Cav1-mRFP constructs (Fig. 1 A). Expression of wild-
type Cav1-mRFP is elevated relative to endogenous Cav1 as well 
as to the Cav1 Y14 mutants and comparable with endogenous 
Cav1 levels in caveolae-expressing MDA-231 breast carcinoma 
cells (Fig. S1). Interestingly, stable expression of Cav1Y14D 
and Y14R in MDA-435 cells results in elevated levels of endo-
genous Cav1 and cavin-1. Consistently, Cav1Y14D- and Y14R-
expressing MDA-435 cells presented numerous caveolae and 
caveolae clusters by EM (Fig. 1, B and C). Surprisingly, expres-
sion of Cav1wt does not induce a significant increase in caveola 
density (Fig. 1, B and C). However, in Cav1/ mouse embryo 
fibroblasts (MEFs), in which exogenous Cav1 induces caveola 
formation (Kirkham et al., 2008), all the Y14 Cav1-myc-mRFP 
constructs induce caveola formation (Fig. S2 A). Furthermore, 
interaction between Cav1-mRFP and cavin-1–GFP, measured 
using fluorescence lifetime measurement (FLIM), is equivalent 
for all Y14 mutants (Fig. S2 B). This suggests that Cav1 Y14 phos-
phorylation impacts neither on Cav1 interaction with cavin-1 nor 
on the ability of Cav1 to induce caveolae. In Cav1wt-expressing 
MDA-435 cells, Cav1 levels either remain below the threshold 
for caveola formation, or endogenous cavin-1 levels are in-
sufficient. Induction of caveolae in the Cav1Y14D and Y14R 
MDA-435 transfectants may be related to elevated expression 
of endogenous Cav1 and cavin-1.
Both Cav1Y14D and Y14R functionally mimic tyrosine-
phosphorylated Cav1, activating RhoA GTPase and stabilizing 
FAK-GFP in focal adhesions (Goetz et al., 2008; Joshi et al., 
2008). RhoA GTP levels are elevated in stable Cav1wt, Y14D, 
and Y14R MDA-435 transfectants (Fig. 2 A). RhoA activation 
and recruitment of its effector Rho-associated kinase (ROCK) 
leads to focal adhesion maturation and actin stress fiber forma-
tion (Jaffe and Hall, 2005); however, only the Cav1Y14D and 
Y14R MDA-435 transfectants present increased actin stress 
fibers and cell spreading (Fig. 2 B). Similar effects of both nega-
tively charged Y14D and positively charged Y14R Cav1 mutants 
suggest that pCav1 is not acting via SH2 domain recruitment of 
Csk, Grb2, or other effectors (Lee et al., 2000; Cao et al., 2002) 
but rather through conformational changes associated with 
altered actin cytoskeleton organization (Goetz et al., 2008).
Inhibition of actin polymerization with latrunculin A 
(LatA) prevents, whereas actin stabilization with jasplakino-
lide enhances, induction of Cav1 and cavin-1 in Cav1Y14D- and 
Y14R-transfected MDA-435 cell lines (Fig. 2 C). Jasplakinolide 
treatment also induces Cav1/cavin-1 expression in Cav1wt-
transfected cells but not control or Cav1Y14F-transfected cells 
as does stimulation of Cav1 phosphorylation by oxidative stress 
using hydrogen peroxide and sodium orthovanadate (H2O2/
vanadate; Volonté et al., 2001). Prevention of cell spreading on 
bacterial plates inhibits induction of endogenous Cav1 and cavin-
1 in Cav1Y14D and Y14R cells, whereas mechanical stretching 
(repeated [36×] 30-min stretched and relaxed cycles) on a FlexCell 
device induces Cav1 and cavin-1 in Cav1wt-transfected cells 
(Fig. 2 C). Tyrosine phosphorylation of both endogenous Cav1 
and Cav1wt-RFP are induced by H2O2/vanadate, jasplakino-
lide, and mechanical stretching, whereas LatA eliminates the 
detectable phosphorylation of Cav1wt-RFP (Fig. 2 D). H2O2/
vanadate and jasplakinolide also stimulate pCav1 expression in 
Cav1Y14D and Y14R, but not in dsRed or Cav1Y14F, stable 
MDA-435 transfectants (Fig. 2 E). Tyrosine phosphorylation of 
Cav1 is therefore a mechanotransducer that regulates expression 
of Cav1 and cavin-1 and thereby caveolae.
pCav1 regulation of Cav1 and cavin-1 is 
mediated by the Egr1 transcription factor
Semiquantitative RT-PCR shows the significant elevation of 
Cav1 and, to a lesser extent, cavin-1 mRNA in Cav1Y14D- and 
Y14R-transfected MDA-435 cell lines (Fig. 3 A), suggesting 
that their expression is regulated at the transcriptional level. 
Egr1 is a zinc finger protein and transcription factor that binds 
promoter regions overlapping consensus Sp1 sites (Shingu and 
Bornstein, 1994; Kubosaki et al., 2009). RhoA activation, actin 
stress fiber formation, and mechanical stretching increase 
expression of Egr1 (Nose and Ohba, 1996; Chen et al., 2010; 
Wu et al., 2010). Promoter analysis identifies several putative 
Egr1 binding sites within GC-rich clusters overlapping SP1 
binding sites in the 1,000-bp promoter region upstream of the 
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Figure 2. pCav1 impacts actin stress fiber formation and cell spreading. (A) Activated RhoA-GTP was assessed by rhotekin pull-down in MDA-435 stable 
transfectants expressing dsRed, Cav1wt, or Y14 mutants. (B) MDA-435 stable transfectants were fluorescently labeled with Alexa Fluor 488–phalloidin, and 
cell spreading was determined by scan array 48 h after plating (*, P < 0.05; **, P < 0.001). Bar, 10 µm. (C) Effect of actin depolymerization with LatA, 
actin stabilization with jasplakinolide and H2O2/vanadate, prevention of cell spreading by plating cells on bacterial plates (Bac.Plate), and mechanical cell 
stretching (36 cycles of 30-min stretched and relaxed cycles on Bioflex 6-well plates) on endogenous Cav1, cavin-1, and -actin levels was determined 
by Western blotting in MDA-435 Cav1 transfectants. (D) Cav1wt cells were not treated (NT) or treated with H2O2/vanadate, jasplakinolide (Jasp.), 
429Caveola biogenesis via pCav1 mechanotransduction • Joshi et al.
mechanical cell stretching, or LatA and Western blotted for pCav1, Cav1, and -actin. Densitometric quantification is presented as a bar graph (*, P < 0.05). 
(E) MDA-435 stable transfectants were treated with H2O2/vanadate, jasplakinolide, or LatA and Western blotted for pCav1, Cav1, and -actin. Error bars 
show means ± SEM.
 
start codon and the initial 200 bp of the first exon of both the 
Cav1 and cavin-1 promoters (Fig. 3 B).
Egr1 is a substrate of PKC and casein kinase II and, when 
phosphorylated, fails to avidly bind to DNA (Huang and Adamson, 
1995; Jain et al., 1996; Huang et al., 1998; Srivastava et al., 1998). 
The dramatic shift in Egr1 mobility in Cav1Y14D- and Y14R-
expressing cells is indicative of its phosphorylation (Fig. 3 C; 
Cao et al., 1990; Day et al., 1990). dsRed-, Cav1wt-, and Y14F-
expressing MDA-435 cell lines express the 60-kD nonphos-
phorylated Egr1 protein, whereas both Cav1Y14D and Y14R 
Figure 3. pCav1 transcriptional regulation of Cav1 and cavin-1 is mediated by Egr1. (A) Semiquantitative (Semi-Quant.) RT-PCR of Cav1 and cavin-1 tran-
script levels in stable MDA-435 Cav1 transfectants. (right) Bar graphs show normalized (against glyceraldehyde 3-phosphate dehydrogenase [GAPDH]) 
values for Cav1 and cavin-1 PCR products (*, P < 0.05). Error bars show means ± SEM. (B) Schematic diagrams of Cav1 and cavin-1 promoter analysis 
show several putative Egr1 binding sites (gray circles) within an 1-kb area (between 1,000 and 200) comprising the 1,000 bp upstream from the start 
codon and the first exon of the Cav1 and cavin-1 promoters. Egr1 sites overlap with SP1 binding sites and reside within GC-rich clusters. (C) Cell lysates 
of stable MDA-435 Cav1 transfectants were Western blotted for Egr1 and -actin. Cav1Y14D- and Y14R-expressing cells present reduced levels of active 
nonphosphorylated (bottom band) and increased levels of the inactive phosphorylated (top band) Egr1. (bottom) Mechanical stretching (30-min stretched 
and relaxed cycles over 48 h) induces phosphorylation of Egr1 in Cav1wt- but not control dsRed- or dominant-negative Cav1Y14F-expressing MDA-435 
stable cell lines. (D) Egr1 siRNA knockdown induces Cav1 and cavin-1 in Cav1wt- but not control dsRed- or dominant-negative Cav1Y14F-expressing 
MDA-435 stable cells. Ctl, control.
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activity of both promoters (Fig. 4 A). Furthermore, Cav1 and 
cavin-1 promoter activity is selectively elevated in Cav1Y14D- 
and Y14R-expressing MDA-435 cell lines, matching the increased 
endogenous Cav1 and cavin-1 protein expression in these 
cells (Fig. 4 B). Consistently, oxidative stress (H2O2/vana-
date) and mechanical stretching selectively induce Cav1 and 
cavin-1 promoter activity in Cav1wt- but not dsRed control- or 
Cav1Y14F-expressing MDA-435 cells (Fig. 4, C and D). Egr1 
regulation of Cav1 and cavin-1 promoter activity is therefore 
pCav1 dependent.
Occupancy of the endogenous Cav1 or cavin-1 promoters 
by Egr1 was determined using chromatin immunoprecipitation 
(CHIP) assays. In Cav1Y14D and Y14R MDA-435 cell lines, 
Egr1 binding to the 1-kb promoter region of both the Cav1 
and cavin-1 genes is reduced relative to dsRed, Cav1wt, and 
Y14F lines (Fig. 4 E). Equivalent input DNA for all the lines 
transfectants have significantly higher levels of inactive phos-
phorylated Egr1 (80 kD). Egr1 phosphorylation is induced 
in Cav1wt- but not dsRed- or Cav1Y14F-expressing cells by 
mechanical stretching cycles that increase endogenous Cav1 
and cavin-1 levels (Fig. 3 C). siRNA knockdown of Egr1 in-
creases levels of endogenous Cav1 and cavin-1 but only in 
Cav1wt-expressing line (Fig. 3 D). No effect is observed in 
dsRed or Cav1Y14F stable MDA-435 cell lines, suggesting that 
the mechanotransduced Egr1 suppressive effect is dependent 
on Cav1Y14 phosphorylation. Our data suggest that mechanical 
stress increases Egr1 phosphorylation and inhibition of its 
suppressive activity. As a suppressor of both Cav1 and cavin-1 
transcription, Egr1 is therefore a critical and novel regulator of 
caveola biogenesis.
Cotransfection of Cav1 and cavin-1 promoter luciferase 
reporter plasmids with an Egr1-expressing plasmid reduces the 
Figure 4. Egr1 suppression of Cav1 and cavin-1 promoters is pCav1 dependent. (A) MDA-435 cells were transiently transfected with control pRL, Cav1-
luciferase (Luc), or cavin-1–luciferase promoter constructs with or without pcDNA3-Egr1 and subjected to luciferase reporter assay. (B) Stable MDA-435 
Cav1 transfectants were transfected with Cav1-luciferase and cavin-1–luciferase reporter constructs and subjected to luciferase reporter assay. (C) Cav1-
luciferase and cavin-1–luciferase promoter activity in nontreated (NT) or H2O2/vanadate-stimulated MDA-435 Cav1 transfectants. (D) FlexCell mechanical 
stretching induces Cav1 and cavin-1 promoter reporter activity in MDA-435 Cav1 transfectants. (E) CHIP assays of stable Cav1 MDA-435 transfectants 
showed markedly reduced promoter occupancy by Egr1 in Cav1Y14D- and Y14R-expressing stables. Negative control IgG immunoprecipitation is shown. 
(F) H2O2/vanadate or FlexCell mechanical stretching reduce Egr1 occupation of Cav1 and cavin-1 promoter sites in Cav1wt relative to dsRed- and 
Cav1Y14F-transfected MDA-435 cell lines (*, P < 0.05; **, P < 0.001). Ctrl, control. Error bars show means ± SEM.
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while significant, is reduced in amplitude relative to Cav1 
mRNA (Fig. 3 A). Differential impact on Cav1 and cavin-1 ex-
pression at both the mRNA and protein levels in MDA-231 cells 
may reflect cell-specific promoter regulation and protein stability. 
Cav1 gene expression is regulated by NF-B and SP1 (Dasari 
et al., 2006; Volonte and Galbiati, 2011), and pCav1-PKC-Egr1 
may be one of multiple mechanisms that regulate Cav1 and 
cavin-1 expression. Indeed, Cav1 and cavin-1 gene expression 
is selectively induced in Cav1wt- but not control dsRed- or 
dominant-negative Cav1Y14F-transfected MDA-435 cells 
by actin stabilization, mechanical stretch, or Egr1 knockdown 
(Figs. 2 C and 3 D). In the breast cancer cell models studied 
here, Egr1 transcriptional regulation of Cav1 and cavin-1 gene 
expression therefore requires pCav1 and is specific to Cav1- 
expressing cells.
Cav1 therefore represents a mechanosensor that transduces 
increased actin cytoskeleton–focal adhesion tension to regulate 
Cav1 and cavin-1 gene expression and thereby supply caveolae to 
buffer membrane tension in response to mechanical stress (Sinha 
et al., 2011). Endothelial Cav1 and caveolae are required for 
mechanotransduction in blood vessels (Yu et al., 2006). Mechani-
cal and oxidative stress induce Cav1 phosphorylation (Volonté 
et al., 2001; Radel and Rizzo, 2005), including a role for p38 
MAPK/Sp1 gene transcription (Dasari et al., 2006; Volonte and 
Galbiati, 2011). In cancer cells, tissue stiffness promotes malig-
nancy through integrin-mediated focal adhesion and Rho/
ROCK-generated contractility (Paszek et al., 2005). Together 
with pCav1 activation of RhoA and Rho/ROCK-dependent 
phosphorylation of Cav1 (Grande-García et al., 2007; Joshi et al., 
2008), this suggests that pCav1 may be a central regulator of a 
positive feedback loop that responds to mechanical stress and 
thereby promotes Rho/ROCK-dependent tumor cell migration.
In conclusion, we have identified a pathway linking force-
induced phosphorylation of Cav1 with transcriptional regula-
tion of key components of caveolar biogenesis. Posttranslational 
modification of Cav1 (i.e., Y14 tyrosine phosphorylation) 
enables it to function as a reporter of cellular tension that feed-
backs to regulate, via Egr1 transcriptional regulation of Cav1 
and cavin-1, the plasma membrane abundance of an organelle 
critical to the cellular response to mechanical stress.
Materials and methods
Antibodies and reagents
Antibodies to Egr1 and RhoA were obtained from Santa Cruz Biotechnol-
ogy, Inc., to -actin were obtained from Sigma-Aldrich, to Cav1 and cavin-1 
were obtained from BD, and to pCav1 were obtained from Cell Signaling 
Technology. Alexa Fluor 488–phalloidin was purchased from Molecular 
Probes. Jasplakinolide, LatA, R0, staurosporine, PMA, hydrogen peroxide 
(H2O2), and sodium orthovanadate (Na2VO4) were obtained from Sigma-
Aldrich. PP2 and Y27632 were obtained from EMD Millipore. Egr1-targeting 
SMARTpool siRNA was purchased from Thermo Fisher Scientific. OneStep 
StopGlo was obtained from Promega.
Plasmids, luciferase, and CHIP assays
C-terminal–tagged myc/mRFP-tagged Cav1wt, Y14F, Y14D, and Y14R 
under control of the cytomegalovirus promoter in pcDNA3 plasmid and 
cavin-1–GFP in pEGFP-N1 were as previously described (Goetz et al., 
2008; Hill et al., 2008; Joshi et al., 2008). Control pRL, Cav1-luciferase, 
and cavin-1–luciferase plasmids were purchased from SwitchGear, and 
their expression was assayed using a luciferase detection kit (Promega) 
and the lack of a PCR product in the IgG pull-down indicate the 
specificity of Egr1 binding. FlexCell mechanical stretch-
ing and H2O2/vanadate both selectively reduce Egr1 inter-
action with the promoter regions of the Cav1 and cavin-1 genes 
in Cav1wt-expressing cells (Fig. 4 F). These results suggest a 
feedback mechanism whereby pCav1 actively employs the Egr1 
transcription factor to autoregulate its own expression as well 
as that of cavin-1.
Endogenous Cav1 regulates Egr1 promoter 
regulation in MDA-231 breast cancer cells
In the metastatic MDA-231 breast carcinoma cell line that ex-
presses elevated Cav1, pCav1, and caveolae (Kojic et al., 2007; 
Joshi et al., 2008), Cav1 and cavin-1 promoter activity is en-
hanced by actin stabilization with jasplakinolide or by H2O2/
vanadate and reduced by Cav1 knockdown and LatA treatment 
(Fig. 5 A). The ability of jasplakinolide, H2O2/vanadate, and 
LatA to modulate Cav1 and cavin-1 promoter activity is Cav1 
dependent as promoter activity is restored to control levels in 
the presence of Cav1 siRNA. CHIP assays were performed on 
the same set of cells transfected with control or Cav1-specific 
siRNAs (Fig. 5 B). Treatment with H2O2/vanadate or jas-
plakinolide reduces physical occupancy by Egr1 of the Cav1 
and cavin-1 promoters, whereas LatA treatment enhances Egr1 
promoter occupancy. However, these effects on Egr1 promoter 
occupancy are not observed upon siRNA knockdown of Cav1 
in MDA-231 cells. Endogenous Cav1 is therefore required for 
Egr1 regulation of Cav1 and cavin-1 promoter activity in these 
metastatic breast cancer cells.
To identify signaling pathways that mediate pCav1-Egr1 
control of Cav1 and cavin-1 gene expression, we treated MDA-
231 cells with the Src kinase inhibitor PP2, the ROCK inhibitor 
Y27632, and the PKC inhibitors R0 and staurosporine. In PP2- 
and Y27632-treated MDA-231 cells, pCav1 is no longer de-
tected, as previously reported (Joshi et al., 2008), but pCav1 is 
still present in cells treated with the PKC inhibitors R0 and 
staurosporine. The PKC activator PMA does not affect pCav1 
levels but does significantly increase Cav1 expression (Fig. 5 C). 
As observed for Cav1-expressing MDA-435 cells, both jas-
plakinolide treatment and cell stretching induce Cav1 ex-
pression in MDA-231 cells. All four kinase inhibitors reduce 
jasplakinolide induction of Cav1, although not cavin-1, levels 
(Fig. 5 D). This suggests that although PP2 and Y27632 prevent 
jasplakinolide induction of Cav1 by preventing Cav1 phosphor-
ylation, PKC acts downstream of pCav1 to regulate actin- 
dependent induction of Cav1.
We then tested the effect of these drugs on Cav1 and cavin-1 
promoter activity. PP2, Y27632, R0, and staurosporine reduce 
and PMA increases Cav1 and, to a lesser extent, cavin-1 pro-
moter activity in untreated (Fig. 5 E) and jasplakinolide-treated 
(Fig. 5 F) MDA-231 cells. Src, ROCK, and PKC inhibition of 
jasplakinolide-induced Cav1 and cavin-1 promoter activity is 
not observed in Egr1 knockdown cells and therefore mediated 
by Egr1 (Fig. 5 F). Relative to Cav1, control of cavin-1 pro-
moter activity and protein expression levels by pCav1 and Egr1 
is reduced in MDA-231 cells (Fig. 5, C–E). Similarly, cavin-1 
mRNA induction in Cav1Y14D and Y14R MDA-435 cells, 
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Figure 5. Transcriptional regulation of Cav1 and cavin-1 through endogenous Cav1 in metastatic MDA-231 breast cancer cells. (A, top) Metastatic 
MDA-231 breast cancer cells treated with jasplakinolide (Jasp.), H2O2/vanadate (H2O2/van), or LatA or transfected with control (Ctrl si) or Cav1 
siRNAs were  then transiently transfected with control pRL, Cav1-luciferase (Luc), or cavin-1–luciferase constructs for 48 h and subjected to luciferase 
assay. (bottom) Altered promoter activity caused by jasplakinolide, H2O2/vanadate, or LatA treatment is Cav1 dependent as it is not observed in Cav1 
siRNA–transfected cells. (B) CHIP assays for Egr1 binding to Cav1 and cavin-1 promoters in MDA-231 cells were performed after H2O2/vanadate, 
jasplakinolide, or LatA treatment on control (Ctrl) or Cav1 siRNA–transfected cells. Negative control IgG immunoprecipitation is shown. (C) MDA-231 
cells were not treated (NT) or treated with PP2, Y27632, R0, or staurosporine (Stauro; left) or with PMA (right) and then Western blotted for pCav1, 
Cav1, cavin-1, and -actin (**, P < 0.001). (D) MDA-231 cells treated with jasplakinolide or mechanically stretched (left) or treated with jasplakinolide 
and either PP2, Y27632, R0, or staurosporine (right) were Western blotted for Cav1, cavin-1, and -actin. (E) MDA-231 cells transiently transfected 
with Cav1-luciferase or cavin-1–luciferase for 48 h were subjected to luciferase assay after treatment with PP2, Y27632, R0, staurosporine (Stauro), or 
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PMA. (F) MDA-231 cells were cotransfected with Cav1-luciferase or cavin-1–luciferase and either control (siCtl) or Egr1 (siEgr1) siRNA and treated with 
jasplakinolide and either PP2, Y27632, R0, or staurosporine before luciferase assay (*, P < 0.05). Error bars show means ± SEM.
 
and a luminometer (Lumat LB 9507; Berthold Technologies). CHIP assays 
were performed as previously described (Joshi et al., 2005). In brief, cells 
treated with 1% formaldehyde for 10 min at room temperature to cross-
link protein–DNA complexes were harvested, washed three times with 
PBS, lysed in 1% SDS, 50 mM Tris-HCI, pH 8.1, and 1 mM EDTA, and 
sonicated twice (10 W for 15 s). Cell debris was pelleted at 4°C, and 
the supernatant was incubated with either 3 µg anti-Egr1 antibody or IgG 
in dilution buffer (0.01% SDS, 16.7 mM Tris-HCI, pH 8.1, 1.2 mM 
EDTA, 150 mM NaCl, and 1% Triton X-100) and rotated overnight at 4°C. 
Antibody DNA–protein complexes were pulled down with protein A– 
Sepharose beads, washed, and then decross-linked by incubating at 65°C 
for 4 h. DNA was ethanol precipitated, subjected to proteinase K treatment 
for 30 min at 37°C, and repurified before using for PCR. The following 
sets of primers were used to assess Egr1 binding to Cav1 or cavin-1 promot-
ers: 5-TGGAGAGGCAGATAGCAGAAGCGG-3 and 5-GATCTTCATTTCT-
TATTTCGAAGCG-3; or 5-TGCCCATCTTAATTCTACTCTGTTAGG-3 and 
5-GACTTGATCAGCTCTTCTGAG-3.
Cell lines, cell stretching, and drug treatment
Stable MDA-435 cell lines expressing dsRed, Cav1wt-mRFP, Cav1Y14F-
mRFP, Cav1Y14R-mRFP, or Cav1Y14D-mRFP were generated as described 
previously (Joshi et al., 2008). In brief, 48 h after Effectene transfection, 
cells were selected with 400 µg/ml G418 for 2 wk, and resistant cells 
were FACS sorted. Cells were maintained in DME medium containing 10% 
FBS, penicillin/streptomycin, and 50 µg/ml geneticin (Gibco; Invitrogen). 
All cell lines were passaged at least twice after recovery from frozen stocks 
before initiating experiments and maintained in culture for a maximum 
of 8–10 passages to minimize phenotypic drift. For cyclic stretch experi-
ments, cells were seeded and grown on untreated silicone elastomer- 
bottomed plates (Bioflex) overnight before subjecting them to cyclic stretch 
in a strain unit (FX-4000T Flexercell; FlexCell). Cells were exposed to an 
equiaxial stretch of 5% at a frequency of 1 Hz after a cycle of 30-min 
stretching and 30-min relaxation for a total of 36 repeats. Cells were treated 
with 3 mM hydrogen peroxide–1 mM sodium vanadate for 45–60 min 
to induce oxidative stress and with 150 nM LatA for 30 min to depolymerize 
actin microfilaments and jasplakinolide (MDA-231, 100 nm; MDA-435, 
150 nm) for 2 h to stabilize the actin cytoskeleton (Sun et al., 2009; 
Shankar et al., 2010). Cells transiently transfected with reporter constructs 
were treated 36–42 h after transfection. Where indicated, cells were 
treated with 5 µM PP2, 10 µM Y27632, 4 µM R0, 100 nM staurosporine, 
or 150 nM PMA for 2 h.
EM
Stable MDA-435 cell lines or transiently transfected Cav1/ immortalized 
MEFs expressing the indicated constructs were fixed in the presence of 
ruthenium red to highlight the cell surface (Hill et al., 2008) and pro-
cessed by conventional methods for Epon embedding. Cav1/ cells were 
sectioned parallel to the substratum, and images were captured using a 
transmission electron microscope (1011; JEOL) equipped with a cooled 
charge-coupled device camera (Morada; Olympus) and with AnalySIS soft-
ware (Olympus) at a magnification of 15,000–20,000×. For quantification 
of caveolae density in MDA-435 cell lines, sections were cut perpendicular 
to the cell surface (vertical sections) to ensure random sampling of the entire 
plasma membrane. Complete cells were identified by EM, and the number 
of ruthenium red–labeled 55–70-nm uncoated circular profiles (i.e., caveo-
lae) was counted per cell profile. Data were generated from analysis of ≥45 
cell profiles per line (from three independent cultures of each line).
FLIM, immunofluorescence, cell spreading, Western blots,  
RhoA-GTP assay, and semiquantitative RT-PCR
FLIM of Cav1/ MEFs transfected with cavin-1–GFP (donor) and mRFP-Cav1wt 
and Y14 mutants (acceptor) was performed using a lifetime fluorescence 
imaging attachment (Lambert Instruments) on an inverted microscope 
(IX71; Olympus) as previously described (Hill et al., 2008). Cells were 
excited using a sinusoidally modulated 3-W 470-nm light-emitting diode 
at 80 MHz under epi-illumination and imaged with a 60×, NA 1.45 oil 
objective using an appropriate GFP filter set. The phase and modulation 
were determined from a set of 12 phase settings, and pixel resolution 
of two lifetimes in the frequency domain was performed using the polar 
plot method as implemented in the manufacturer’s software.
To label F-actin, cells were fixed with 3% paraformaldehyde and 
permeabilized with 0.1% Triton X-100 before incubation with Alexa Fluor 
568–phalloidin. Coverslips were mounted in Airvol (Air Products, Inc.), 
and images were collected with the 100× Plan Apochromat objective, NA 
1.35, of a confocal microscope (FV1000; Olympus). To quantify cell area, 
cells labeled with Alexa Fluor 568–phalloidin and Hoechst on 96-well 
plates were scanned using the 10× objective of an automated fluorescence 
microscope (ArrayScan; Cellomics, Inc.), and cell area was measured on 
five fields/well using the Morphology Explorer BioApplication software 
(Cellomics, Inc.) module as previously described (Shankar et al., 2010). 
Western blots and semiquantitative RT-PCR were as previously described 
(Joshi et al., 2008). Antibody dilutions for Western blots were as follows: 
1:1,000 for pCav1, Cav1, and cavin-1, 1:500 for Egr1, 1:10,000 for 
-actin, and 1:3,000 for HRP anti–mouse or anti–rabbit. RhoA-GTP 
pull-downs were performed with rhotekin beads according to the suppli-
er’s protocol (EMD Millipore) and probed by Western blotting for RhoA 
(active and total; 1:1,000 antibody dilution) as previously described (Joshi 
et al., 2008). Transcript levels were determined by PCR (25 cycles) from 
total cDNA using primer sets for Cav1, 5-TCTCTACACCGTTCCCATCC-3 
and 5-TCCCTTCTGGTTCTGCAATC-3; cavin-1, 5-CAAGGCCACCGA-
GATGGTGGA-3 and 5-GAAGTTCGGAAGGAGCGAGGA-3; and 
glyceraldehyde 3-phosphate dehydrogenase, 5-GGTCGGAGTCAACG-
GATTTGGTCG-3 and 5-CCTCCGACGCCTGCTTCACCAC-3.
Online supplemental material
Fig. S1 shows Cav1 expression by Western blotting in the MDA-435 Cav1 
Y14 transfectants relative to endogenous Cav1 in MDA-231 cells. Fig. S2 
shows that Cav1/ MEF expression of mRFP-tagged Cav1wt, Y14F, Y14D, 
or Y14R induces caveolae by EM and their equivalent interaction with 
cavin-1–GFP by FLIM analysis. Online supplemental material is available 
at http://www.jcb.org/cgi/content/full/jcb.201207089/DC1.
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